BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8466951)

  • 1. A comparative study of low-density lipoprotein interaction with glycosaminoglycans.
    Gigli M; Ghiselli G; Torri G; Naggi A; Rizzo V
    Biochim Biophys Acta; 1993 Apr; 1167(2):211-7. PubMed ID: 8466951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of the low density lipoprotein-glycosaminoglycan interaction.
    Sambandam T; Baker JR; Christner JE; Ekborg SL
    Arterioscler Thromb; 1991; 11(3):561-8. PubMed ID: 2029496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin binding to human plasma low-density lipoproteins: dependence on heparin sulfation degree and chain length.
    Gigli M; Consonni A; Ghiselli G; Rizzo V; Naggi A; Torri G
    Biochemistry; 1992 Jul; 31(26):5996-6003. PubMed ID: 1627542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of chondroitin 6-sulfate to plasma low density lipoprotein.
    Mourão PA; Pillai S; Di Ferrante N
    Biochim Biophys Acta; 1981 May; 674(2):178-87. PubMed ID: 6786361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
    Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins.
    Leta GC; Mourão PA; Tovar AM
    Biochim Biophys Acta; 2002 Apr; 1586(3):243-53. PubMed ID: 11997076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of low density lipoproteins with charged ligands: a study using the fluorescent probe 1-aniline naphthalene-8-sulfonate].
    Kuznetsov AS; Khovratovich VI; Ioffe DV; Popov AV
    Vopr Med Khim; 1983; 29(4):61-5. PubMed ID: 6414179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of high molecular weight chondroitin sulfate from human aorta with plasma low density lipoproteins.
    Alves CS; Mourão PA
    Atherosclerosis; 1988 Oct; 73(2-3):113-24. PubMed ID: 3142491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix.
    Shuvaev VV; Laffont I; Siest G
    FEBS Lett; 1999 Oct; 459(3):353-7. PubMed ID: 10526164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
    Harris EN; Weigel PH
    Glycobiology; 2008 Aug; 18(8):638-48. PubMed ID: 18499864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan specificity of a heparin-binding peptide.
    Taylor GJ; Yorke SC; Harding DR
    Pept Res; 1995; 8(5):286-93. PubMed ID: 8589551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.
    Cardoso LE; Mourão PA
    Arterioscler Thromb; 1994 Jan; 14(1):115-24. PubMed ID: 8274466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
    Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
    Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
    Volpi N
    Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction.
    Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1989 Nov; 1006(2):159-66. PubMed ID: 2512982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral atherosclerosis in Japanese part 6: the interaction of plasma lipoproteins with glycosaminoglycans isolated from the cerebral arteries and aortas.
    Nakashima Y; Nakamura M; Kikuchi Y
    Artery; 1981; 9(2):151-5. PubMed ID: 6457588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders.
    Soares da Costa D; Reis RL; Pashkuleva I
    Annu Rev Biomed Eng; 2017 Jun; 19():1-26. PubMed ID: 28226217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble complex formation between low-density lipoprotein and glycosaminoglycans. A 2H and 31P-NMR, and quasi-elastic light scattering study.
    Fenske DB; Cushley RJ
    Chem Phys Lipids; 1988 Nov; 49(1-2):15-29. PubMed ID: 3148373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.